Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00595725 · ClinicalTrials.gov registry record · NA

Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma

A NA study of Endometrial Cancer and Cervical Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
151
Enrollment target
1
Study location

NCT00595725 is a NA study of Endometrial Cancer and Cervical Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 151 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00595725, a NA study of Endometrial Cancer and Cervical Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
151 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn if a surgical technique called intraoperative lymphatic mapping can accurately identify the lymph node that is at greatest risk if endometrial or cervical cancer spreads to the lymph nodes. Early cervical cancer is usually treated by removing the cervix, tissue around the cervix, and the upper vagina. If needed, the uterus is also removed. The treatment also includes removing lymph nodes from the pelvis. Endometrial cancer is usually treated by removing the cervix, uterus, fallopian tubes and ovaries. The treatment also includes removing lymph nodes from the pelvis.

Interventions

  • OTHER Lymphatic Mapping

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2003-02
Est. Completion 2011-09
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00595725

The ClinicalTrials.gov registry entry for NCT00595725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (71% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Lymphatic Mapping is the first listed.

NCT00595725 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00595725 about?

NCT00595725 is a clinical study titled "Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma". The purpose of this study is to learn if a surgical technique called intraoperative lymphatic mapping can accurately identify the lymph node that is at greatest risk if endometrial or cervical cancer spreads to the lymph nodes. Early cervical cancer is usually treated by removing the cervix, tissue...

What is the current status of trial NCT00595725?

This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2003-02. Estimated completion is 2011-09.

What conditions does trial NCT00595725 study?

This clinical trial studies the following conditions: Endometrial Cancer, Cervical Cancer, Cervical Carcinoma.

What interventions are being tested in trial NCT00595725?

The interventions under investigation include: Lymphatic Mapping (OTHER).

Who is sponsoring clinical trial NCT00595725?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00595725 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.